These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 9329578

  • 1. Cyfra 21-1 and TPA as markers in malignant mesothelioma.
    Bonfrer JM, Schouwink JH, Korse CM, Baas P.
    Anticancer Res; 1997; 17(4B):2971-3. PubMed ID: 9329578
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen.
    Bonfrer JM, Gaarenstroom KN, Korse CM, Van Bunningen BN, Kenemans P.
    Anticancer Res; 1997; 17(3C):2329-34. PubMed ID: 9245246
    [Abstract] [Full Text] [Related]

  • 4. Value of Cyfra 21-1, TPA, and SCC-Ag in predicting extracervical disease and prognosis in cervical cancer.
    Gaarenstroom KN, Bonfrer JM, Korse CM, Kenter GG, Kenemans P.
    Anticancer Res; 1997; 17(4B):2955-8. PubMed ID: 9329574
    [Abstract] [Full Text] [Related]

  • 5. Monitoring of therapy in inoperable lung cancer patients by measurement of CYFRA 21-1, TPA- TP CEA, and NSE.
    Ebert W, Hoppe M, Muley T, Drings P.
    Anticancer Res; 1997; 17(4B):2875-8. PubMed ID: 9329552
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
    Gaarenstroom KN, Kenter GG, Bonfrer JM, Korse CM, Van de Vijver MJ, Fleuren GJ, Trimbos JB.
    Gynecol Oncol; 2000 Apr; 77(1):164-70. PubMed ID: 10739706
    [Abstract] [Full Text] [Related]

  • 8. Analysis of serum CYFRA 21-1 concentrations in patients with esophageal cancer.
    Brockmann JG, St Nottberg H, Glodny B, Sprakel B, Senninger N.
    Anticancer Res; 2000 Apr; 20(6D):4899-904. PubMed ID: 11332443
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Increased CYFRA 21-1 and CEA levels are negative predictors of outcome in p-stage I NSCLC.
    Muley T, Dienemann H, Ebert W.
    Anticancer Res; 2003 Apr; 23(5b):4085-93. PubMed ID: 14666606
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. CYFRA 21-1, TPA-M, TPS, SCC-Ag and CEA in patients with squamous cell lung cancer and in chemical industry workers as a reference group.
    Kulpa J, Wójcik E, Radkowski A, Kolodziejski L, Stasik Z.
    Anticancer Res; 2000 Apr; 20(6D):5035-40. PubMed ID: 11326663
    [Abstract] [Full Text] [Related]

  • 19. Tissue polypeptide antigen (TPA), hyaluronan and CA 125 as serum markers in malignant mesothelioma.
    Hedman M, Arnberg H, Wernlund J, Riska H, Brodin O.
    Anticancer Res; 2003 Apr; 23(1B):531-6. PubMed ID: 12680141
    [Abstract] [Full Text] [Related]

  • 20. CYFRA 21-1 serum analysis in patients with esophageal cancer.
    Brockmann JG, St Nottberg H, Glodny B, Heinecke A, Senninger NJ.
    Clin Cancer Res; 2000 Nov; 6(11):4249-52. PubMed ID: 11106239
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.